Daegu, South Korea

Jungwook Chin

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Jungwook Chin: Innovative Minds in Pharmaceutical Advancements**

Introduction

Jungwook Chin is an accomplished inventor hailing from Daegu, South Korea. With a keen focus on pharmaceuticals, he holds two patents centered around novel aryl ethene derivatives that contribute significantly to medical advancements.

Latest Patents

Chin's latest patents revolve around an aryl ethene derivative designed to inhibit estrogen-related receptor gamma (ERRγ) activity. These patents include not just the derivative itself but also its prodrugs, solvates, stereoisomers, and pharmaceutically acceptable salts. Furthermore, the composition containing these derivatives serves as a critical active ingredient for various pharmaceutical applications.

Career Highlights

Throughout his career, Jungwook Chin has made notable contributions to the field of medical innovation. He has collaborated with prominent institutions such as the Daegu-Gyeongbuk Medical Innovation Foundation and Kyungpook National University Hospital. These roles have allowed him to drive research in developing new therapeutic agents that tackle critical health issues.

Collaborations

During his professional journey, Chin has had the opportunity to collaborate with talented individuals like Sung Yeoun Hwang and Sung Jin Cho. Their teamwork has been pivotal in enhancing the efficacy and application of Chin's innovative concepts.

Conclusion

Jungwook Chin stands out as a significant contributor to the pharmaceutical field through his inventive spirit and commitment to addressing critical health challenges. His patents showcasing aryl ethene derivatives demonstrate the potential for groundbreaking advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…